291 related articles for article (PubMed ID: 21154121)
1. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
Bisht S; Brossart P; Maitra A; Feldmann G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling and pancreatic tumor development.
Lauth M; Toftgård R
Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226
[TBL] [Abstract][Full Text] [Related]
3. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
5. Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma.
Dimou A; Syrigos K; Saif MW
JOP; 2011 Jan; 12(1):1-5. PubMed ID: 21206093
[TBL] [Abstract][Full Text] [Related]
6. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
7. Advances in pancreatic cancer.
Kim EJ; Simeone DM
Curr Opin Gastroenterol; 2011 Sep; 27(5):460-6. PubMed ID: 21778878
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.
Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M
Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.
Feldmann G; Habbe N; Dhara S; Bisht S; Alvarez H; Fendrich V; Beaty R; Mullendore M; Karikari C; Bardeesy N; Ouellette MM; Yu W; Maitra A
Gut; 2008 Oct; 57(10):1420-30. PubMed ID: 18515410
[TBL] [Abstract][Full Text] [Related]
10. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy.
Tremblay MR; Nesler M; Weatherhead R; Castro AC
Expert Opin Ther Pat; 2009 Aug; 19(8):1039-56. PubMed ID: 19505195
[TBL] [Abstract][Full Text] [Related]
11. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
O'Toole SA; Swarbrick A; Sutherland RL
Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
[TBL] [Abstract][Full Text] [Related]
12. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
Kiesslich T; Neureiter D
Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
[TBL] [Abstract][Full Text] [Related]
13. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived proangiogenic cells in pancreatic cancer.
Mizukami Y
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
Scales SJ; de Sauvage FJ
Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
[TBL] [Abstract][Full Text] [Related]
16. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications.
Yang L; Xie G; Fan Q; Xie J
Oncogene; 2010 Jan; 29(4):469-81. PubMed ID: 19935712
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog Signaling in Pancreatic Fibrosis and Cancer.
Bai Y; Bai Y; Dong J; Li Q; Jin Y; Chen B; Zhou M
Medicine (Baltimore); 2016 Mar; 95(10):e2996. PubMed ID: 26962810
[TBL] [Abstract][Full Text] [Related]
18. Stromal response to Hedgehog signaling restrains pancreatic cancer progression.
Lee JJ; Perera RM; Wang H; Wu DC; Liu XS; Han S; Fitamant J; Jones PD; Ghanta KS; Kawano S; Nagle JM; Deshpande V; Boucher Y; Kato T; Chen JK; Willmann JK; Bardeesy N; Beachy PA
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3091-100. PubMed ID: 25024225
[TBL] [Abstract][Full Text] [Related]
19. Aberrations and therapeutics involving the developmental pathway Hedgehog in pancreatic cancer.
Kelleher FC; McDermott R
Vitam Horm; 2012; 88():355-78. PubMed ID: 22391312
[TBL] [Abstract][Full Text] [Related]
20. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
Feldmann G; Fendrich V; McGovern K; Bedja D; Bisht S; Alvarez H; Koorstra JB; Habbe N; Karikari C; Mullendore M; Gabrielson KL; Sharma R; Matsui W; Maitra A
Mol Cancer Ther; 2008 Sep; 7(9):2725-35. PubMed ID: 18790753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
